tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Richard Law, 52 are a HOLD (47.27%), 50 are a BUY (45.45%), 8 are a SELL (7.27%).
Analyst Richard Law, currently employed at GOLDMAN SACHS, carries an average stock price target met ratio of 52.92% that have a potential upside of 41.1% achieved within 179 days. Previously, Richard Law worked at CREDIT SUISSE.
Richard Law’s has documented 217 price targets and ratings displayed on 23 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on RCKT, Rocket Pharmaceuticals.
Analyst best performing recommendations are on OLMA (OLEMA PHARMACEUTICALS).
The best stock recommendation documented was for OLMA (OLEMA PHARMACEUTICALS) at 11/21/2025. The price target of $26 was fulfilled within 4 days with a profit of $2.83 (12.21%) receiving and performance score of 30.54.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 05-Mar-2026
$21
$13.36 (174.87%)
$24
2 months ago
(10-Aug-2026)
8/22 (36.36%)
$12.01 (133.59%)
106
Buy Since 25-Feb-2026
$14
$6.36 (83.25%)
$19
2 months ago
(10-Aug-2026)
0/2 (0%)
$5.01 (55.73%)
Hold Since 18-Sep-2025
$12
$4.36 (57.07%)
$11
2 months 5 days ago
(05-Aug-2026)
12/19 (63.16%)
$3.6 (42.86%)
129
Buy Since 09-May-2024
$11
$3.36 (43.98%)
$15
2 months 5 days ago
(05-Aug-2026)
1/8 (12.5%)
$2.6 (30.95%)
400
Buy Since 12-Mar-2025
$18
$10.36 (135.60%)
$18
2 months 6 days ago
(04-Aug-2026)
0/7 (0%)
$9 (100.00%)
Which stock is Richard Law most bullish on?
Which stock is Richard Law most reserved on?
What Year was the first public recommendation made by Richard Law?
